|
Year
|
Title
|
Authors
|
Publication
|
|
2018
|
Autologous transplantation versus allogeneic transplantation in patients with follicular lymphoma experiencing early treatment failure.
|
Smith SM, Godfrey J, Ahn KW, DiGilio A, Ahmed S, Agrawal V, Bachanova V, Bacher U, Bashey A, Bolaños-Meade J, Cairo M, Chen A, Chhabra S, Copelan E, Dahi PB, Aljurf M, Farooq U, Ganguly S, Hertzberg M, Holmberg L, Inwards D, Kanate AS, Karmali R, Kenkre VP, Kharfan-Dabaja M, Klein A, Lazarus HM, Mei M, Mussetti A, Nishihori T, Ramakrishnan Geethakumari P, Saad A, Savani BN, Schouten HC, Shah N, Urbano-Ispizua A, Vij R, Vose J, Sureda A, Hamadani M
|
Cancer
|
|
2018
|
Donor telomere length and causes of death after unrelated hematopoietic cell transplant in patients with marrow failure.
|
Gadalla SM, Aubert G, Wang T, Haagenson M, Spellman SR, Wang L, Katki HA, Savage SA, Lee SJ
|
Blood
|
|
2018
|
Exomechip analyses identify genes affecting mortality after HLA-matched unrelated donor blood and marrow transplantation.
|
Zhu Q, Yan L, Liu Q, Zhang C, Wei L, Hu Q, Preus L, Clay-Gilmour AI, Onel K, Stram DO, Pooler L, Sheng X, Haiman CA, Zhu X, Spellman SR, Pasquini MC, McCarthy P, Liu S, Hahn T, Sucheston-Campbell LE
|
Blood
|
|
2018
|
Tocilizumab, tacrolimus and methotrexate for the prevention of acute graft-versus-host disease: Low incidence of lower gastrointestinal tract disease.
|
Drobyski WR, Szabo A, Zhu F, Keever-Taylor C, Hebert KM, Dunn R, Yim S, Johnson B, D'Souza A, Eapen M, Fenske TS, Hari P, Hamadani M, Horowitz MM, Rizzo JD, Saber W, Shah N, Shaw B, Pasquini M
|
Haematologica 103(4):717-727
|
|
2018
|
Tandem autologous hematopoietic cell transplantation for patients with primary progressive or recurrent Hodgkin lymphoma: A SWOG and Blood and Marrow Transplant Clinical Trials Network phase II Trial (SWOG S0410/BMT CTN 0703).
|
EP Smith, H Li, Friedberg JW, L Constine, L Rimsza, Cook JR, Laport GG, Popplewell LL, Holmberg LA, Smith S, LeBlanc M, Forman SJ, Fisher R, Stiff P
|
Biol Blood Marrow Transplant 24(4):700-707
|
|
2018
|
Early relapse after autologous hematopoietic cell transplantation remains a poor prognostic factor in multiple myeloma but outcomes have improved over time.
|
Kumar SK, Dispenzieri A, Fraser R, Mingwei F, Akpek G, Cornell R, Kharfan-Dabaja M, Freytes C, Hashmi S, Hildebrandt G, Holmberg L, Kyle R, Lazarus H, Lee C, Mikhael J, Nishihori T, Tay J, Usmani S, Vesole D, Vij R, Wirk B, Krishnan A, Gasparetto C, Mark T, Nieto Y, Hari P, D'Souza A
|
Leukemia 32(4):986-995
|
|
2018
|
Late cardiovascular morbidity and mortality following pediatric allogeneic hematopoietic cell transplantation.
|
Duncan CN, Brazauskas R, Huang J, Shaw BE, Majhail NS, Savani BN, Flowers MED, Battiwalla M, Beebe K, Dietz AC, Dvorak CC, Giller R, Jacobsohn DA, Kletzel M, Martin PL, Nemecek ER, Nuechterlein B, Talano JA, Pulsipher MA, Baker KS
|
Bone Marrow Transplant
|
|
2018
|
Providing level-of-match information to perfectly matched unrelated donors: Evaluating acceptability and potential changes in donor availability.
|
Switzer GE, Macis M, Macis M, Fabi R, Fabi R, Abress L, Abress L, Confer D, Confer D, Bruce J, Bruce J, Howe K, Howe K, Fowler S, Fowler S, McNulty M, McNulty M, Pastorek G, Dew MA
|
Biol Blood Marrow Transplant
|
|
2018
|
Country-level macroeconomic indicators predict early post-allogeneic hematopoietic cell transplantation survival in acute lymphoblastic leukemia: A CIBMTR analysis.
|
Wood WA, Brazauskas R, Hu ZH, Abdel-Azim H, Ahmed IA, Aljurf M, Badawy S, Beitinjaneh A, George B, Buchbinder D, Cerny J, Dedeken L, Diaz MA, Freytes CO, Ganguly S, Gergis U, Almaguer DG, Gupta A, Hale G, Hashmi S, Inamoto Y, Kamble RT, Adekola K, Kindwall-Keller T, Knight J, Kumar L, Kuwatsuka Y, Law J, Lazarus HM, LeMaistre C, Olsson RF, Pulsipher MA, Savani BN, Schultz KR, Saad A, Seftel M, Seo S, Shea TC, Steinberg A, Sullivan K, Szwajcer D, Wirk B, Yared J, Yong A, Dalal J, Hahn T, Khera N, Bonfim C, Atsuta Y, Saber W
|
Biol Blood Marrow Transplant
|
|
2018
|
A Group Sequential Test for Treatment Effect based on the Fine-Gray Model.
|
Martens M, Logan BR
|
Biometrics
|
|
2018
|
Severity, course, and predictors of sleep disrution following hematopoietic cell transplantation: A secondary data analysis from the BMT CTN 0902 trial
|
Jim HSL, Sutton S, Najhail NS, Wood WA, Jacobsen PB, Wingard JR, Wu, J, Knight JM, Syrjala KL, Lee SJ
|
Bone Marrow Transplant
|
|
2018
|
Prevalence of self-reported sleep dysfunction before allogeneic hematopoietic cell transplantation.
|
D'Souza A, Millard H, Knight J, Brazauskas R, Lee SJ, Flynn KE, Rizzo JD, Shaw BE
|
Bone Marrow Transplant
|
|
2018
|
Association between recipient TNF rs361525 and acute GVHD: Results from analysis of BMT CTN-0201 samples.
|
Rashidi A, Shanley R, Yohe SL, Thyagarajan B, Curtsinger J, Anasetti C, Waller EK, Miller J S, Blazar B, Weisdorf D J
|
Bone Marrow Transplant
|
|
2018
|
Assessment of impact of HLA type on outcomes of allogeneic hematopoietic stem cell transplantation for chronic lymphocytic leukemia.
|
Hill BT, Ahn KW, Hu Z-H, Aljurf M, Beitinjaneh A, Cahn J-Y, Cerny J, Kharfan-Dabaja MA, Ganguly S, Ghosh N, Grunwald MR, Inamoto Y, Kindwall-Keller T, Nishihori T, Olsson RF, Saad A, Seftel M, Seo S, Szer J, Tallman M, Ustun C, Wiernik PH, Maziarz RT, Kalaycio M, Alyea E, Popat U, Sobecks R, Saber W
|
Biol Blood Marrow Transplant 24(3):581-586
|
|
2018
|
Autologous/allogeneic Hematopoietic cell transplantation versus tandem autologous transplantation for multiple myeloma: Comparison of long-term postrelapse survival.
|
Htut M, D'Souza A, Krishnan A, Bruno B, Zhang M-J, Fei M, Diaz MA, Copelan E, Ganguly S, Hamadani M, Kharfan-Dabaja M, Lazarus H, Lee C, Meehan K, Nishihori T, Saad A, Seo S, Ramanathan M, Usmani SZ, Gasparetto C, Mark TM, Nieto Y, Hari P
|
Biol Blood Marrow Transplant 24(3):478-485
|
|
2018
|
Influence of age on acute and chronic GVHD in children undergoing HLA-identical sibling bone marrow transplantation for acute leukemia: Implications for prophylaxis.
|
Qayed M, Wang T, Hemmer MT, Spellman S, Arora M, Couriel D, Alousi A, Pidala J, Abdel-Azim H, Aljurf M, Ayas M, Bitan M, Cairo M, Choi SW, Dandoy C, Delgado D, Gale RP, Hale G, Frangoul H, Kamble RT, Kharfan-Dabaja M, Lehman L, Levine J, MacMillan M, Marks DI, Nishihori T, Olsson RF, Hematti P, Ringden O, Saad A, Satwani P, Savani BN, Schultz KR, Seo S, Shenoy S, Waller EK, Yu L, Horowitz MM, Horan J
|
Biol Blood Marrow Transplant 24(3):521-528
|
|
2018
|
Cohort-controlled comparison of umbilical cord blood transplantation using carlecortemcel-L, a single progenitor-enriched cord blood, to double cord blood unit transplantation.
|
Stiff PJ, Montesinos P, Peled T, Landau E, Rosenheimer Goudsmid N, Mandel J, Hasson N, Olesinski E, Glukhman E, Snyder DA, Galamidi Cohen E, Srur Kidron O, Bracha D, Harati D, Ben-Abu K, Freind E, Freedman LS, Cohen YC, Olmer L, Barishev R, Rocha V, Gluckman E, Horowitz MM, Eapen M, Nagler A, Sanz G
|
Biol Blood Marrow Transplant
|
|
2018
|
Variable selection with group structure in competing risks quantile regression.
|
Ahn KW, Kim S
|
Stat Med
|
|
2018
|
Microbiome-host interactions in hematopoietic stem-cell transplant recipients.
|
Andermann T, Peled J, Ho C, Reddy P, Riches M, Storb R, Teshima T, van den Brink M, Alousi A, Balderman S, Chiusolo P, Clark W, Holler E, Howard A, Kean L, Koh A, McCarthy P, McCarty J, Mohty M, Nakamura R, Rezvani K, Segal B, Shaw B, Shpall E, Sung A, Weber D, Whangbo J, Wingard J, Wood W, Perales M-A, Jenq R, Bhatt A
|
Biol Blood Marrow Transplant
|
|
2018
|
PROMIS measures can be used to assess symptoms and function in long-term hematopoietic cell transplantation survivors.
|
Shaw BE, Syrjala KL, Onstad LE, Chow EJ, Flowers ME, Jim H, Baker KS, Buckley S, Fairclough DL, Horowitz MM, Lee SJ
|
Cancer 124(4):841-849
|
|
2018
|
Long-term outcomes among 2-year survivors of autologous hematopoietic cell transplantation for Hodgkin and diffuse large b-cell lymphoma.
|
Myers RM, Hill BT, Shaw BE, Kim S, Millard HR, Battiwalla M, Majhail NS, Buchbinder D, Lazarus HM, Savani BN, Flowers MED, D'Souza A, Ehrhardt MJ, Langston A, Yared JA, Hayashi RJ, Daly A, Olsson RF, Inamoto Y, Malone AK, DeFilipp Z, Margossian SP, Warwick AB, Jaglowski S, Beitinjaneh A, Fung H, Kasow KA, Marks DI, Reynolds J, Stockerl-Goldstein K, Wirk B, Wood WA, Hamadani M, Satwani P
|
Cancer 124(4):816-825
|
|
2018
|
Development of an unrelated donor selection score predictive of survival after HCT: Donor age matters most.
|
Shaw BE, Logan BR, Spellman SR, Marsh SGE, Robinson J, Pidala J, Hurley C, Barker J, Maiers M, Dehn J, Wang H, Haagenson M, Porter D, Petersdorf EW, Woolfrey A, Horowitz MM, Verneris MR, Hsu KC, Fleischhauer K, Lee SJ
|
Biol Blood Marrow Transplant
|
|
2018
|
Effect of donor characteristics on haploidentical transplantation with posttransplantation cyclophosphamide.
|
McCurdy SR, Zhang M-J, St Martin A, Al Malki MM, Bashey A, Gaballa S, Keesler DA, Hamadani M, Norkin M, Perales M-A, Reshef R, Rocha V, Romee R, Solh M, Urbano-Ispizua A, Waller EK, Fuchs EJ, Eapen M
|
Blood Advances 2(3):299-307
|
|
2018
|
Allogeneic hematopoietic stem cell transplantation for relapsed follicular lymphoma: A combined analysis on behalf of the Lymphoma Working Party of the EBMT and the Lymphoma Committee of the CIBMTR.
|
Sureda A, Zhang M-J, Dreger P, Carreras J, Fenske T, Finel H, Schouten H, Montoto S, Robinson S, Smith SM, Boumedil A, Hamadani M, Pasquini MC
|
Cancer
|
|
2018
|
HLA mismatches that are identical for the antigen recognition domain are less immunogenic.
|
Roelen D, de Vaal Y, Vierra-Green C, Waldvogel S, Spellman S, Claas F, Oudshoorn M
|
Bone Marrow Transplant
|
|
2018
|
Engaging patients in setting a patient-centered outcomes research agenda in hematopoietic cell transplantation
|
Burns LJ, Abetti B, Arnold SD, Bender J, Doughtie S, El-Jawahiri A, Gee G, Hahn T, Horowitz MM, Johnson S, Juckett M, Krishnamurit L, Kullberg S, LeMaistre CF, Loren A, Majhail NS, Murphy EA, Rizzo D, Roche-Green A, Saber W, Schatz BA, Schmit-Pokorny K, Shaw BE, Syrjala KL, Tierney DK, Ulrich C, Vanness DJ, Wood WA, Denzen EM
|
Biol Blood Marrow Transplant
|
|
2018
|
Evaluation of a machine learning-based prognostic model for unrelated hematopoietic cell transplantation donor selection.
|
Buturovic L, Shelton J, Spellman SR, Wang T, Friedman L, Loftus D, Hesterberg L, Woodring T, Fleischhauer K, Hsu KC, Verneris MR, Haagenson M, Lee SJ
|
Biol Blood Marrow Transplant
|
|
2018
|
Neurocognitive dysfunction in hematopoietic cell transplant recipients: Expert review from the Late Effects and Quality of Life Working Committee of the Center for International Blood and Marrow Transplant Research and Complications and Quality of Life Working Party of the European Society for Blood and Marrow Transplantation.
|
Kelly DL, Buchbinder D, Duarte RF, Auletta JJ, Bhatt N, Byrne M, DeFilipp Z, Gabriel M, Mahindra A, Norkin M, Schoemans H, Shah AJ, Ahmed I, Atsuta Y, Basak GW, Beattie S, Bhella S, Bredeson C, Bunin N, Dalal J, Daly A, Gajewski J, Gale RP, Galvin J, Hamadani M, Hayashi RJ, Adekola K, Law J, Lee CJ, Liesveld J, Malone AK, Nagler A, Naik S, Nishihori T, Parsons SK, Scherwath A, Schofield H-L, Soiffer R, Szer J, Twist I, Warwick A, Wirk BM, Yi J, Battiwalla M, Flowers ME, Savani B, Shaw BE
|
Biol Blood Marrow Transplant 24(2):228-241
|
|
2018
|
Current knowledge and practice of pediatric providers in umbilical cord blood banking.
|
Armstrong AE, Fonstad R, Spellman S, Tullius Z, Chaudhury S
|
Clin Pediatr (Phila) 57(2):161-167
|
|
2018
|
Donor body mass index does not predict graft versus host disease following hematopoietic cell transplantation.
|
Turcotte LM, Wang T, Hemmer MT, Spellman SR, Arora M, Couriel D, Alousi A, Pidala J, Abdel-Azim H, Ahmed I, Beitinjaneh A, Buchbinder D, Byrne M, Callander N, Chao N, Choi SW, DeFlilipp Z, Gadalla SM, Gale RP, Gergis U, Hashmi S, Hematti P, Holmberg L, Inamoto Y, Kamble RT, Lehmann L, MacMillan MA, McIver Z, Nishihori T, Norkin M, O'Brien T, Olsson RF, Reshef R, Saad A, Savani B, Schouten HC, Seo S, Solh M, Verdonck L, Vij R, Wirk B, Yared J, Horowitz MM, Knight JM, Verneris MR
|
Bone Marrow Transplant
|
|
2018
|
Prediction of acute graft-versus-host disease following hematopoietic cell transplantation.
|
Lee C, Haneuse S, Wang H-L, Rose S, Spellman SR, Verneris MR, Hsu KC, Fleischhauer K, Lee SJ, Abdi R
|
PLoS One 13(1):e0190610
|
|
2018
|
Neurocognitive dysfunction in hematopoietic cell transplant recipients: Expert review from the Late Effects and Quality of Life working committee of the CIBMTR and Complications and Quality of Life working party of the EBMT.
|
Buchbinder D, Kelly DL, Duarte RF, Auletta JJ, Bhatt N, Byrne M, DeFlilipp Z, Gabriel M, Mahindra A, Norkin M, Schoemans H, Shah AJ, Ahmed I, Atsuta Y, Basak GW, Beattie S, Bhella S, Bredeson C, Bunin N, Dalal J, Daly A, Gajewski J, Gale RP, Galvin J, Hamadani M, Hayashi RJ, Law J, Lee CJ, Liesveld J, Malone AK, Nagler A, Naik S, Nishihori T, Parsons SK, Scherwath A, Schofield HL, Soiffer R, Szer J, Twist I, Warwick AB, Wirk BM, Yi J, Battiwalla M, Flowers MDE, Savani B, Shaw BE
|
Bone Marrow Transplant
|
|
2018
|
Next generation sequencing characterizes the extent of HLA diversity in an Argentinian registry population.
|
Hurley CK, Hou L, Lazaro A, Gerfen J, Enriquez E, Galarza P, Cardozo MBR, Halagan M, Maiers M, Behm D, Ng J
|
HLA
|
|
2018
|
Blood and Marrow Transplant Clinical Trials Network Report on Development of Novel Endpoints and Selection of Promising Approaches for Graft-Versus-Host Disease Prevention Trials
|
Pasquini MC, Logan B, Jones RJ, Alousi AM, Appelbaum FR, Bolanos-Meade J, Flowers MED, Giralt S, Horowitz MM, Jacobsohn, D, Koreth J, Levine JE, Luznik L, Maziarz, Mendizabal A, Pavletic, Perales MA, Porter, David, Reshef Ran, Weisdorf D, Antin JH
|
Biol Blood Marrow Transplant
|
|
2018
|
Outcome of hematopoietic cell transplantation for DNA double-strand break repair disorders.
|
Slack J, Albert MH, Balashov D, Belohradsky BH, Bertaina A, Bleesing J, Booth C, Buechner J, Buckley RH, Ouachée-Chardin M, Deripapa E, Drabko K, Eapen M, Feuchtinger T, Finocchi A, Gaspar HB, Ghosh S, Gillio A, Gonzalez-Granado LI, Grunebaum E, Güngör T, Heilmann C, Helminen M, Higuchi K, Imai K, Kalwak K, Kanazawa N, Karasu G, Kucuk ZY, Laberko A, Lange A, Mahlaoui N, Meisel R, Moshous D, Muramatsu H, Parikh S, Pasic S, Schmid I, Schuetz C, Schulz A, Schultz KR, Shaw PJ, Slatter MA, Sykora K-W, Tamura S, Taskinen M, Wawer A, Wolska-Kuśnierz B, Cowan MJ, Fischer A, Gennery AR
|
J Allergy Clin Immunol 141(1):322-328.e10
|
|
2018
|
Donor and recipient plasma follistatin levels are associated with acute GvHD in Blood and Marrow Transplant Clinical Trials Network 0402.
|
Turcotte LM, DeFor TE, Newell LF, Cutler CS, Verneris MR, Wu J, Howard A, MacMillan ML, Antin JH, Vercellotti GM, Slungaard A, Blazar BR, Weisdorf DJ, Panoskaltsis-Mortari A, Holtan SG
|
Bone Marrow Transplant 53(1):64-68
|
|
2018
|
Donor experiences of second marrow or peripheral blood stem cell collection mirror the first, but CD34+ yields are less.
|
Stroncek DF, Shaw BE, Logan BR, Kiefer DM, Savani BN, Anderlini P, Bredeson CN, Hematti P, Ganguly S, Diaz MA, Abdel-Azim H, Ahmed I, Maharaj D, Seftel M, Beitinjaneh A, Seo S, Yared JA, Halter J, O'Donnell PV, Hale GA, DeFilipp Z, Lazarus H, Liesveld JL, Zhou Z, Munshi P, Olsson RF, Kasow KA, Szer J, Switzer GE, Chitphakdithai P, Shah N, Confer DL, Pulsipher MA
|
Biol Blood Marrow Transplant 24(1):175-184
|
|
2018
|
Fludarabine and busulfan versus fludarabine, cyclophosphamide, and rituximab as reduced-intensity conditioning for allogeneic transplantation in follicular lymphoma.
|
Epperla N, Ahn KW, Armand P, Jaglowski S, Ahmed S, Kenkre VP, Savani B, Jagasia M, Shah NN, Fenske TS, Sureda A, Smith SM, Hamadani M
|
Biol Blood Marrow Transplant 24(1):78-85
|
